CHICAGO—Ruder Finn has been named agency of record for Efoora, a Buffalo Grove, IL-based developer of rapid, diagnostic products best known for its strides in disease tests (including mad cow and chronic wasting tests), rapid HIV testing, and its patent protected PRIMOS blood glucose monitoring platform.
The agency has been engaged to develop and implement a comprehensive communications program that will focus primarily on three significant products expected to receive approval from the United States Food and Drug Administration (FDA) and the United States Department of Agriculture (USDA) within the next six months.
“Ruder Finn has both an excellent reputation and a proven ability to generate impressive communications results,” says David Grosky, chairman of the board of directors and chief executive officer of Efoora. “It offers a tremendous amount of experience and expertise in the biotech and healthcare arenas, and we expect it to play a significant role in helping us expand awareness of our products and technology platforms.”
Ruder Finn’s Chicago and Los Angeles offices will jointly service the account. Howard Solomon, executive vice president, U.S. regional operations for Ruder Finn in Chicago, and healthcare industry veteran Kathy Vincent, vice president, will be co-leaders on the team.